<DOC>
	<DOC>NCT00234442</DOC>
	<brief_summary>The aim of the study is to determine if Iressa is effective in the treatment of Brain metastases from NCSLC</brief_summary>
	<brief_title>Iressa in the Treatment of Brain Metastases From Non Small Cell Lung Cancer</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma, Non-Small-Cell Lung</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Brain Neoplasms</mesh_term>
	<mesh_term>Gefitinib</mesh_term>
	<criteria>Radiologically confirmed brain metastases from Non Small Cell Lung Cancer No symptoms due to brain metastases No previous radiotherapy treatment for the Brain metastases No prior chemotherapy No other coexisting malignancies or malignancies diagnosed within the last 5 years with the exception of basal cell carcinoma or cervical cancer in situ Any evidence of severe or uncontrolled systemic disease (e.g., unstable or uncompensated respiratory, cardiac, hepatic, or renal disease)</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2009</verification_date>
	<keyword>Non symptomatic brain metastases</keyword>
	<keyword>Iressa</keyword>
</DOC>